Next Article in Journal
Oleyl Conjugated Histidine-Arginine Cell-Penetrating Peptides as Promising Agents for siRNA Delivery
Previous Article in Journal
Tolmetin Sodium Fast Dissolving Tablets for Rheumatoid Arthritis Treatment: Preparation and Optimization Using Box-Behnken Design and Response Surface Methodology
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Kazmi et al. Formulation and Evaluation of Kaempferol Loaded Nanoparticles against Experimentally Induced Hepatocellular Carcinoma: In Vitro and In Vivo Studies. Pharmaceutics 2021, 13, 2086

1
Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2
Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia
3
School of Pharmacy, Suresh Gyan Vihar University, Jaipur 302017, India
4
Department of Pharmacology, Saveetha Dental College, Saveetha University, Chennai 600077, India
*
Author to whom correspondence should be addressed.
Pharmaceutics 2022, 14(4), 882; https://doi.org/10.3390/pharmaceutics14040882
Submission received: 23 March 2022 / Accepted: 7 April 2022 / Published: 18 April 2022
In the original publication [1], there was a mistake in Figure 2 as published. The image of Figure 2 was not clear. The corrected Figure 2 appears below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original publication has also been updated.

Reference

  1. Kazmi, I.; Al-Abbasi, F.A.; Afzal, M.; Altayb, H.N.; Nadeem, M.S.; Gupta, G. Formulation and Evaluation of Kaempferol Loaded Nanoparticles against Experimentally Induced Hepatocellular Carcinoma: In Vitro and In Vivo Studies. Pharmaceutics 2021, 13, 2086. [Google Scholar] [CrossRef] [PubMed]
Figure 2. FTIR spectra of the Kaempferol (pure drug) and the prepared Kaempferol nanoparticle.
Figure 2. FTIR spectra of the Kaempferol (pure drug) and the prepared Kaempferol nanoparticle.
Pharmaceutics 14 00882 g001
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kazmi, I.; Al-Abbasi, F.A.; Afzal, M.; Altayb, H.N.; Nadeem, M.S.; Gupta, G. Correction: Kazmi et al. Formulation and Evaluation of Kaempferol Loaded Nanoparticles against Experimentally Induced Hepatocellular Carcinoma: In Vitro and In Vivo Studies. Pharmaceutics 2021, 13, 2086. Pharmaceutics 2022, 14, 882. https://doi.org/10.3390/pharmaceutics14040882

AMA Style

Kazmi I, Al-Abbasi FA, Afzal M, Altayb HN, Nadeem MS, Gupta G. Correction: Kazmi et al. Formulation and Evaluation of Kaempferol Loaded Nanoparticles against Experimentally Induced Hepatocellular Carcinoma: In Vitro and In Vivo Studies. Pharmaceutics 2021, 13, 2086. Pharmaceutics. 2022; 14(4):882. https://doi.org/10.3390/pharmaceutics14040882

Chicago/Turabian Style

Kazmi, Imran, Fahad A. Al-Abbasi, Muhammad Afzal, Hisham N. Altayb, Muhammad Shahid Nadeem, and Gaurav Gupta. 2022. "Correction: Kazmi et al. Formulation and Evaluation of Kaempferol Loaded Nanoparticles against Experimentally Induced Hepatocellular Carcinoma: In Vitro and In Vivo Studies. Pharmaceutics 2021, 13, 2086" Pharmaceutics 14, no. 4: 882. https://doi.org/10.3390/pharmaceutics14040882

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop